SENSEX
NIFTY
GOLD
USD/INR

Weather

image 23    C

Economy News

News

Economy / The Economic Times

details

Glenmark launches fixed-dose triple therapy for COPD

Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three medicines to improve lung function and symptom control. It offers a new standard of care, especially for patients who find inhalers difficult. The therapy showed rapid improvement in lung function and breathlessness in a clinical study.

25 Nov 2025 2:29 pm